These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 17143708

  • 1. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies.
    Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T.
    Heart Vessels; 2006 Nov; 21(6):344-9. PubMed ID: 17143708
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.
    Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Nagamura Y, Kondo T, Oshima H, Nomura M, Ezaki K, Hishida H.
    Clin Chem; 2003 Dec; 49(12):2020-6. PubMed ID: 14633873
    [Abstract] [Full Text] [Related]

  • 3. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.
    Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T.
    Circ J; 2007 May; 71(5):631-5. PubMed ID: 17456983
    [Abstract] [Full Text] [Related]

  • 4. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.
    Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H.
    Am J Cardiol; 2002 Mar 15; 89(6):691-5. PubMed ID: 11897211
    [Abstract] [Full Text] [Related]

  • 5. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 15; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 6. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy.
    Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, Yamamoto T, Horie M.
    Circ J; 2011 May 15; 75(3):656-61. PubMed ID: 21178288
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis.
    Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, Ishikawa T, Kurokawa H, Hirano T, Kondo T, Nagamura Y, Ezaki K, Hishida H.
    Clin Chim Acta; 2001 Oct 15; 312(1-2):69-79. PubMed ID: 11580911
    [Abstract] [Full Text] [Related]

  • 8. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

  • 9. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N, Matsumura Y, Furuno T, Sugiura T, Doi YL.
    J Am Coll Cardiol; 2013 Oct 01; 62(14):1252-1259. PubMed ID: 23623916
    [Abstract] [Full Text] [Related]

  • 10. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies.
    Miller WL, Hartman KA, Burritt MF, Burnett JC, Jaffe AS.
    Clin Cardiol; 2007 May 01; 30(5):245-50. PubMed ID: 17492679
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.
    Abiko M, Inai K, Shimada E, Asagai S, Nakanishi T.
    J Cardiol; 2018 Apr 01; 71(4):389-393. PubMed ID: 29108668
    [Abstract] [Full Text] [Related]

  • 12. Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase.
    Niizuma S, Iwanaga Y, Washio T, Ashida T, Harasawa S, Miyazaki S, Matsumoto N.
    Kidney Blood Press Res; 2019 Apr 01; 44(5):1050-1062. PubMed ID: 31487705
    [Abstract] [Full Text] [Related]

  • 13. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W, Ong-Ajyooth L, Taruangsri P, Pokum S.
    J Med Assoc Thai; 2003 May 01; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [Abstract] [Full Text] [Related]

  • 14. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG, Riedlinger J, Buchner S, Birner C, Resch M, Lubnow M, Debl K, Buesing M, Huedig H, Riegger G, Luchner A.
    Clin Chem Lab Med; 2011 Nov 01; 49(11):1899-906. PubMed ID: 21892905
    [Abstract] [Full Text] [Related]

  • 15. Brain natriuretic peptide correlates with troponin T in patients with renal failure.
    Sahinarslan A, Guz G, Okyay K, Torer N, Bali M, Sindel S, Cengel A.
    Acta Cardiol; 2007 Apr 01; 62(2):171-6. PubMed ID: 17536606
    [Abstract] [Full Text] [Related]

  • 16. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure.
    Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, Januzzi JL.
    Clin Chem; 2007 Mar 01; 53(3):412-20. PubMed ID: 17259237
    [Abstract] [Full Text] [Related]

  • 17. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
    Miller WL, Grill DE, Struck J, Jaffe AS.
    Am J Cardiol; 2013 Mar 15; 111(6):880-5. PubMed ID: 23276468
    [Abstract] [Full Text] [Related]

  • 18. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.
    Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregón R, Brizuela M, Barbagelata A.
    Circulation; 2004 Oct 19; 110(16):2376-82. PubMed ID: 15477403
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Kawasaki T, Sakai C, Harimoto K, Yamano M, Miki S, Kamitani T.
    Am J Cardiol; 2013 Sep 15; 112(6):867-72. PubMed ID: 23746480
    [Abstract] [Full Text] [Related]

  • 20. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure.
    Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kimura T, Kita T.
    Circ J; 2004 Dec 15; 68(12):1160-4. PubMed ID: 15564700
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.